Table 1 Demographic and clinic characteristics and laboratory findings in non-dialysis ESRD patients
Demographics | |
|---|---|
Age (y), mean ± SD | 56.91 ± 14.62 |
Sex (male, %) | 374 (61.20%) |
Etiology of ESRD, n (%) | |
Diabetic nephropathy | 196 (32.08%) |
Hypertensive nephropathy | 101 (16.53%) |
Chronic glomerulonephritis | 179 (29.30%) |
Other | 87 (14.24%) |
Undetermined | 48 (7.85%) |
Blood biochemistry | |
Urea (mmol/L) | 25.75 ± 11.53 |
Creatinine (umol/L) | 805.01 ± 386.83 |
GFR (ml/min per1.73 m2) | 7.83 (5.91–10.55) |
Hemoglobin (g/L) | 75.38 ± 19.09 |
Calcium (mg/dL) | 7.80 ± 1.32 |
Phosphorus (mg/dL) | 5.86 ± 2.36 |
Ca × P (mg2/dL2) | 45.00 ± 17.87 |
Intact Parathormone (pg/mL) | 271.34 (156.12–419.53) |
Albumin (g/L) | 36.13 ± 6.22 |
Ferritin (ng/mL) | 296 (151.10–479.00) |
Leukocytes (109/L) | 7.09 ± 3.19 |
Neutrophils (109/L) | 5.39 ± 2.98 |
Lymphocytes (109/L) | 1.08 ± 0.52 |
Platelets (109/L) | 170.18 ± 74.10 |
Inflammatory markers | |
hs-CRP (mg/L) | 6.87 (1.90–27.70) |
PCT (ng/ml) | 0.61 (0.26–1.96) |
Neutrophil-lymphocyte ratio | 4.48 (3.05–7.32) |
Platelet-lymphocyte ratio | 154.80 (109.98–235.47) |
Comorbidity, n (%) | |
Heart failure | 136 (22.26%) |
Coronary artery disease | 115 (18.82%) |
Cerebrovascular disease | 13 (2.13%) |
Drug use within 1 month, n (%) | |
Steroid | 3 (0.49%) |
Cyclophosphamide | 1 (0.16%) |
Cyclosporine | 1 (0.16%) |